Local drugmakers oppose hospital incentive plan

Published: 2009-12-15 07:00:00

Updated: 2009-12-15 07:00:00

The Korea Pharmaceutical Manufacturers Association (KPMA) and the government have clashed over a new incentive plan, under which a medical institution can get paid the rebate by the government when the institution purchases a drug at a cheaper price than the standard price.

The government plan...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK